Relay Therapeutics' early clinical data for cancer drug RLY-2608 sparked investor concerns due to lack of robust evidence of efficacy, leading to a 40% stock decline. Despite investor skepticism, ...

If you've ever wondered how electronic devices manage to control circuits with precision and safety, you're thinking about the magic of relays. Relays act as the unsung heroes in many of our devices, ...